Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-006736
Filing Date
2025-03-04
Accepted
2025-03-04 19:00:13
Documents
1
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 form4-03042025_070305.html 4  
1 form4-03042025_070305.xml 4 8568
  Complete submission text file 0001415889-25-006736.txt   10229
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CONOR MEDSYSTEMS, INC. 1003 HAMILTON COURT MENLO PARK CA 94025
Business Address
Litvack Frank (Reporting) CIK: 0001310715 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 25707580